170 related articles for article (PubMed ID: 19082447)
1. A new therapeutic modality involving acridine orange excitation by photon energy used during reduction surgery for rhabdomyosarcomas.
Matsubara T; Kusuzaki K; Matsumine A; Murata H; Satonaka H; Shintani K; Nakamura T; Hosoi H; Iehara T; Sugimoto T; Uchida A
Oncol Rep; 2009 Jan; 21(1):89-94. PubMed ID: 19082447
[TBL] [Abstract][Full Text] [Related]
2. A new limb salvage surgery in cases of high-grade soft tissue sarcoma using photodynamic surgery, followed by photo- and radiodynamic therapy with acridine orange.
Nakamura T; Kusuzaki K; Matsubara T; Matsumine A; Murata H; Uchida A
J Surg Oncol; 2008 May; 97(6):523-8. PubMed ID: 18348188
[TBL] [Abstract][Full Text] [Related]
3. Clinical trial of photodynamic therapy using acridine orange with/without low dose radiation as new limb salvage modality in musculoskeletal sarcomas.
Kusuzaki K; Murata H; Matsubara T; Miyazaki S; Okamura A; Seto M; Matsumine A; Hosoi H; Sugimoto T; Uchida A
Anticancer Res; 2005; 25(2B):1225-35. PubMed ID: 15865070
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome of a novel photodynamic therapy technique using acridine orange for synovial sarcomas.
Kusuzaki K; Murata H; Matsubara T; Miyazaki S; Shintani K; Seto M; Matsumine A; Hosoi H; Sugimoto T; Uchida A
Photochem Photobiol; 2005; 81(3):705-9. PubMed ID: 15686440
[TBL] [Abstract][Full Text] [Related]
5. Methylene blue in place of acridine orange as a photosensitizer in photodynamic therapy of osteosarcoma.
Matsubara T; Kusuzaki K; Matsumine A; Satonaka H; Shintani K; Nakamura T; Uchida A
In Vivo; 2008; 22(3):297-303. PubMed ID: 18610739
[TBL] [Abstract][Full Text] [Related]
6. Review. Acridine orange could be an innovative anticancer agent under photon energy.
Kusuzaki K; Murata H; Matsubara T; Satonaka H; Wakabayashi T; Matsumine A; Uchida A
In Vivo; 2007; 21(2):205-14. PubMed ID: 17436568
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of minimally invasive surgery using acridine orange for musculoskeletal sarcomas around the forearm, compared with conventional limb salvage surgery after wide resection.
Matsubara T; Kusuzaki K; Matsumine A; Murata H; Nakamura T; Uchida A; Sudo A
J Surg Oncol; 2010 Sep; 102(3):271-5. PubMed ID: 20740586
[TBL] [Abstract][Full Text] [Related]
8. Flash wave light strongly enhanced the cytocidal effect of photodynamic therapy with acridine orange on a mouse osteosarcoma cell line.
Satonaka H; Kusuzaki K; Matsubara T; Shintani K; Wakabayashi T; Nakamura T; Matsumine A; Uchida A
Anticancer Res; 2007; 27(5A):3339-44. PubMed ID: 17970079
[TBL] [Abstract][Full Text] [Related]
9. Unfiltered xenon light is useful for photodynamic therapy with acridine orange.
Ueda H; Murata H; Takeshita H; Minami G; Hashiguchi S; Kubo T
Anticancer Res; 2005; 25(6B):3979-83. PubMed ID: 16309187
[TBL] [Abstract][Full Text] [Related]
10. Acridine orange used for photodynamic therapy accumulates in malignant musculoskeletal tumors depending on pH gradient.
Matsubara T; Kusuzaki K; Matsumine A; Shintani K; Satonaka H; Uchida A
Anticancer Res; 2006; 26(1A):187-93. PubMed ID: 16475697
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy with acridine orange in musculoskeletal sarcomas.
Matsubara T; Kusuzaki K; Matsumine A; Murata H; Marunaka Y; Hosogi S; Uchida A; Sudo A
J Bone Joint Surg Br; 2010 Jun; 92(6):760-2. PubMed ID: 20513869
[TBL] [Abstract][Full Text] [Related]
12. Acridine orange inhibits pulmonary metastasis of mouse osteosarcoma.
Satonaka H; Kusuzaki K; Akeda K; Tsujii M; Iino T; Uemura T; Matsubara T; Nakamura T; Asanuma K; Matsumine A; Sudo A
Anticancer Res; 2011 Dec; 31(12):4163-8. PubMed ID: 22199275
[TBL] [Abstract][Full Text] [Related]
13. Extracorporeal photodynamic image detection of mouse osteosarcoma in soft tissues utilizing fluorovisualization effect of acridine orange.
Satonaka H; Kusuzaki K; Matsubara T; Shintani K; Wakabayashi T; Matsumine A; Uchida A
Oncology; 2006; 70(6):465-73. PubMed ID: 17237622
[TBL] [Abstract][Full Text] [Related]
14. Periosteal Ewing's sarcoma treated by photodynamic therapy with acridine orange.
Yoshida K; Kusuzaki K; Matsubara T; Matsumine A; Kumamoto T; Komada Y; Naka N; Uchida A
Oncol Rep; 2005 Feb; 13(2):279-82. PubMed ID: 15643511
[TBL] [Abstract][Full Text] [Related]
15. Can a less radical surgery using photodynamic therapy with acridine orange be equal to a wide-margin resection?
Matsubara T; Kusuzaki K; Matsumine A; Nakamura T; Sudo A
Clin Orthop Relat Res; 2013 Mar; 471(3):792-802. PubMed ID: 23008027
[TBL] [Abstract][Full Text] [Related]
16. Long-term clinical outcome in patients with high-grade soft tissue sarcoma who were treated with surgical adjuvant therapy using acridine orange after intra-lesional or marginal resection.
Nakamura T; Kusuzaki K; Matsubara T; Murata H; Hagi T; Asanuma K; Sudo A
Photodiagnosis Photodyn Ther; 2018 Sep; 23():165-170. PubMed ID: 29885811
[TBL] [Abstract][Full Text] [Related]
17. Total tumor cell elimination with minimum damage to normal tissues in musculoskeletal sarcomas following photodynamic therapy with acridine orange.
Kusuzaki K; Aomori K; Suginoshita T; Minami G; Takeshita H; Murata H; Hashiguchi S; Ashihara T; Hirasawa Y
Oncology; 2000 Aug; 59(2):174-80. PubMed ID: 10971178
[TBL] [Abstract][Full Text] [Related]
18. Rhabdomyosarcoma of the extremities in adults.
Hulse N; Raja S; Kumar A; Paul AS
Acta Orthop Belg; 2006 Apr; 72(2):199-203. PubMed ID: 16768266
[TBL] [Abstract][Full Text] [Related]
19. Pediatric sclerosing rhabdomyosarcoma.
Zambrano E; Pérez-Atayde AR; Ahrens W; Reyes-Múgica M
Int J Surg Pathol; 2006 Jul; 14(3):193-9. PubMed ID: 16959698
[TBL] [Abstract][Full Text] [Related]
20. Therapy associated differentiation in rhabdomyosarcomas.
d'Amore ES; Tollot M; Stracca-Pansa V; Menegon A; Meli S; Carli M; Ninfo V
Mod Pathol; 1994 Jan; 7(1):69-75. PubMed ID: 8159655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
